ArticlePharmaceuticals (Basel, Switzerland)2025

Targeting Hyperuricemia and NLRP3 Inflammasome in Gouty Arthritis: A Preclinical Evaluation of Allopurinol and Disulfiram Combination Therapy.

Yahya I Asiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.